Synthetic Glycolipid Ligands for Human iNKT Cells as Potential Therapeutic Agents for Immunotherapy

E-ISSN： 1875-533x|15|23|2337-2345

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.23, 2008-10, pp. : 2337-2345

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential role of iNKT cells in experimental allergic encephalitis and multiple sclerosis

By Roozbeh Maryam Mohammadpour Hemn Azizi Gholamreza Ghobadzadeh Samira Mirshafiey Abbas

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 105-113

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 3, 2005-09 ,pp. : 315-322

Bentham Science Publishers

Access to resources Recommend Favorite

Glycolipid derivatives as therapeutic agents

By Sakai T. Koezuka Y.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 7, 1999-07 ,pp. : 917-930

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents

By O’Neill Paul M

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 9, 2005-09 ,pp. : 1117-1128

Informa Healthcare

Access to resources Recommend Favorite

Role of Invariant Natural Killer T (iNKT) Cells in Systemic Lupus Erythematosus

Current Medicinal Chemistry, Vol. 15, Iss. 18, 2008-08 ,pp. : 1778-1787

Bentham Science Publishers

Access to resources Recommend Favorite